Brookline, MA, United States of America

Heinrich Göttlinger

This inventor holds 1 USPTO granted patent. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Heinrich Göttlinger. Retrieved from https://idiyas.com/inventor/heinrich-gandoumlttlinger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Heinrich Göttlinger: Innovator in Viral Vector Technology

Introduction

Heinrich Göttlinger is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of viral vector technology, particularly in the development of infectious pseudotyped lentiviral vectors. His work has implications for various applications in gene therapy and vaccine development.

Latest Patents

Göttlinger holds a patent titled "Infectious pseudotyped lentiviral vectors lacking matrix protein and uses thereof." This patent describes vector systems that encode viral proteins capable of assembling into an infectious lentivirus particle with a deletion of the lentiviral matrix. In one embodiment, the vectors encode a lentiviral envelope protein that has a deletion of the cytoplasmic tail. In another embodiment, a heterologous envelope is utilized, which targets an endocytic compartment.

Career Highlights

Heinrich Göttlinger is associated with the Dana-Farber Cancer Institute Inc., where he continues to advance research in his field. His innovative approaches have garnered attention and respect within the scientific community.

Collaborations

Some of his notable coworkers include Anatoly Bukovsky and Heide Reil, who have collaborated with him on various projects related to viral vector technology.

Conclusion

Heinrich Göttlinger is a prominent figure in the field of viral vector research, with a patent that showcases his innovative contributions. His work continues to influence advancements in gene therapy and related areas.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…